Received: 22 September 2021
Accepted: 16 March 2022
First Online: 30 May 2022
: The study protocol was approved by institutional Review Board of National Cancer Institute (NCI), Cairo, Egypt, as guided by the 2013 Helsinki Declaration. Written informed consent forms were obtained from each patient for sampling and research.
: Not applicable.
: The authors declare that they have no competing interests.